Table 3 Summary of response of 44 individuals with known response to ketogenic diet
From: Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder
| Â | Age at start of diet (years, median/mean) | Cognitive improvements reported | Side effects reported |
|---|---|---|---|
Responders, 50% (n = 22) | 1.17/1.75 | 32% (n = 7) | 64% (n = 14) |
Non-responders, 50% (n = 22) | 1.92/3.00 | 18% (n = 4) | 27% (n = 6) |